.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for inclusion of clients with MASLD as well as dimension of liver results in cardio-- renal-- metabolic trials, when records propose mechanistically plausible advantages as well as clinical security-- and also lays out considerations for test concept as well as governing commendation.